Nephrol Dial Transplant (1993) 8: 64-70
© 1993 European Renal Association-European Dialysis and Transplant Association
research-article
Clinical evaluation of the peritoneal equilibration test: a population-based study
Renal Unit, North Staffordshire Royal Infirmary Stoke-on-Trent, UK
Correspondence and offprint requests to: Correspondence and offprint requests to: Dr S.J. Davies. Renal Unit, North Staffordshire Royal Inf. Stoke-on-Trent, ST4 7LN. UK
A total of 143 Peritoneal Equilibration Tests (PETs) were performed in 104 CAPD patients over a period of 18 months. A normal range (95% confidence limits) was constructed from 100 tests (68 consecutive new patients, 32 routine tests on problem-free patients) using a 2-dimensional plot of solute transfer (D/Pcreat) and ultrafiltration volume. These two parameters correlated inversely (r= 0.59,P<0.0001) allowing calculation of a regression line. In the short term (<3 months) D/Pcreat was stable across a wide range of values (0.450.98) with good correlation between tests indicating reproducibility (r =0.94, P<0.001). Repeated tests beyond 3 months were variable, explaining changes in the clinical picture, and in the majority of cases shifts in D/Pcreat and ultrafiltration parallelled the regression line for the whole population. Six of seven (85%) of patients with mechanical problems and 14 of 15 (93%) with poor ultrafiltration had at least one abnormal test, and these two problems could be distinguished in 90% of cases by 2-dimensional plotting. In five with ultrafiltration failure, dialysate volumes were less than predicted by solute clearance, and these patients failed continuous cycling peritoneal dialysis (CCPD). In contrast, a good response to CCPD was predicted correctly in five patients with high solute clearance. In nine patients with plasma creatinine >1250µmol/l the PET was normal. The PET is a useful adjunct to understanding and prescribing peritoneal dialysis, particularly when repeated tests are compared to a well-defined normal population.
Keywords: CAPD; peritoneum; PET; ultrafiltration
![]()
CiteULike
Connotea
Del.icio.us What's this?
This article has been cited by other articles:
![]() |
D. G. Struijk Monitoring of the peritoneal membrane NDT Plus, October 1, 2008; 1(suppl_4): iv29 - iv35. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. C. Aanen, D. Venturoli, and S. J. Davies A detailed analysis of sodium removal by peritoneal dialysis: comparison with predictions from the three-pore model of membrane function Nephrol. Dial. Transplant., June 1, 2005; 20(6): 1192 - 1200. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. J. MARGETTS, M. KOLB, T. GALT, C. M. HOFF, T. R. SHOCKLEY, and J. GAULDIE Gene Transfer of Transforming Growth Factor-{beta}1 to the Rat Peritoneum: Effects on Membrane Function J. Am. Soc. Nephrol., October 1, 2001; 12(10): 2029 - 2039. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. J. DAVIES, L. PHILLIPS, P. F. NAISH, and G. I. RUSSELL Peritoneal Glucose Exposure and Changes in Membrane Solute Transport with Time on Peritoneal Dialysis J. Am. Soc. Nephrol., May 1, 2001; 12(5): 1046 - 1051. [Abstract] [Full Text] |
||||
![]() |
S. J. Davies Peritoneal solute transport--we know it is important, but what is it? Nephrol. Dial. Transplant., August 1, 2000; 15(8): 1120 - 1123. [Full Text] [PDF] |
||||


